Glutamatergic Dysfunction In Schizophrenia, The drug PCP acts on glutamate receptors, producing schizophrenia-like symptoms.

Glutamatergic Dysfunction In Schizophrenia, We hypothesized that structural and  Over the past two decades, increasing evidence from preclinical and human studies supports a major role of glutamatergic dysfunction in the aetiopathology  Автор: GJ Marek · 2010 · Цитируется: 194 — The demonstration that a metabotropic glutamate 2/3 (mGlu2/3) receptor agonist prodrug decreased both positive and negative symptoms of schizophrenia raised  Disturbances in glutamate transmission and NMDA receptor hypofunction are associated with schizophrenia. Causes of Schizophrenia. This model  The glutamate hypothesis for schizophrenia asserts that glutamatergic dysfunction is a key causal contributor to both the pathogenesis and  Автор: DC Goff · 1997 · Цитируется: 145 — The excitatory amino acids, glutamate and aspartate, are of interest to schizophrenia research because of their roles in neurodevelopment, neurotoxicity and  Автор: E Scarr · 2005 · Цитируется: 95 — glutamatergic function in the pathology of the disorder. Автор: M Zink · 2015 · Цитируется: 49 — Because glutamate guides processes of brain development and maturation, clinical research should focus on the at-risk mental state or first-episode psychosis,  Автор: G Tsai · 2002 · Цитируется: 809 — Glutamate serves as the neurotransmitter of the pyramidal cells, which are the sources of efferent and interconnecting pathways of the cerebral cortex and  Автор: JM Stone · 2007 · Цитируется: 569 — We consider the case for glutamatergic excitotoxicity as a key process in the development and progression of schizophrenia, and suggest ways in which glutamate  Автор: RC Roberts · 2022 · Цитируется: 39 — Protein levels of vGLUT2, found in subcortical glutamatergic neurons, were increased in the nucleus accumbens in schizophrenia. Neurosci Lett. The NMDA receptor hypofunction hypothesis proposes that  Psychosis is a heterogeneous disorder, with approximately one-third of patients experiencing treatment resistance, predominantly among  Автор: EMP Poels · 2014 · Цитируется: 217 — Two studies measured glutamatergic levels of patients with SCZ in the superior or lateral temporal lobe. Автор: JW Olney · 1995 · Цитируется: 2268 — Hypofunction of the Glu transmitter system was first proposed as a causal mechanism in schizophrenia by Kim et al [27] based on their finding of low  NMDA receptor co-agonists glycine and D-serine are effective in reducing negative symptoms (N = 132, fixed effect model SMD = -0. 2005  Автор: C Tamminga · 1999 · Цитируется: 161 — Glutamatergic neurotransmission has been associated functionally with a number of physiological processes and with certain pathophysiological processes,  Автор: G Tsai · 1998 · Цитируется: 99 — Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction. The  Автор: RD Paz · 2008 · Цитируется: 188 — The underlying cellular mechanisms leading to frontal cortical hypofunction (i. OBJECTIVE To  There's a rich history of research suggesting that glutamate may be involved in the pathogenesis of schizophrenia, with an increasing amount of  Автор: E Papanastasiou · 2013 · Цитируется: 25 — Glutamatergic neurotransmission – relevance to schizophrenia Glutamate is the major excitatory neurotransmitter in the central nervous system  Автор: DC Javitt · 2010 · Цитируется: 436 — Because glutamate/NMDA receptors are located throughout the brain, glutamatergic models predict widespread cortical dysfunction with particular involvement of  Автор: JR Bustillo · 2011 · Цитируется: 132 — Background: Cognitive deficits in schizophrenia may be related to glutamatergic dysfunction, but in vivo measurement of glutamate metabolism has  Автор: JJ Lopes · 2024 · Цитируется: 13 — glutamatergic metabolite levels in adult patients with a schizophrenia spectrum disorder diagnosis. Relationships between regional brain glutamate function and  Автор: HJ Tuominen · 2006 · Цитируется: 169 — Brain glutamate is thought to mediate symptoms in schizophrenia due to the influence of glutamate neurons on the dopaminergic transmission in  The glutamate hypothesis has also gained significant attention in psychosis research. 02 to -0. Reduced NMDA transmission can be primary to D2 dysfunction in some brain areas. Following acute  In schizophrenia models, a consistent theme is hypofunction of NMDARs on distinct neuronal populations, leading to disrupted excitatory–inhibitory balance,  Автор: AD Sherman · 1991 · Цитируется: 188 — The release of glutamate and gamma-aminobutyric acid (GABA) was reduced in the synaptosomes from schizophrenics. This abnormal GLU-GABA-GLU-DA neurocircuit loop now may explain the NMDA receptor hypofunction  An excess of the brain neurotransmitter glutamate may cause a transition to psychosis in people at risk for schizophrenia. •. Existing treatments primarily target dopamine pathways  Автор: A Marsman · 2013 · Цитируется: 641 — Evidence for glu- tamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a  Автор: RC Roberts · 2020 · Цитируется: 39 — The aim of this paper is to summarize ultrastructural evidence for glutamatergic dysregulation in several linked regions in postmortem schizophrenia brain. Abnormalities of the glutamate system are widely recognized to be involved in the pathophysiology of schizophrenia, though the exact mechanism is still  Автор: D Treen · 2016 · Цитируется: 41 — New approaches to underlying alterations in psychosis suggest increasing evidence of glutamatergic abnormalities in schizophrenia and an association between  Results: The NMDAR hypofunction can explain not only the whole range of schizophrenia symptoms but also the dopaminergic dysfunction itself, and it emphasizes  Автор: E Scarr · 2005 · Цитируется: 95 — glutamatergic function in the pathology of the disorder. e. This hypothesis suggests dysfunction in the  Автор: N Zhand · 2019 · Цитируется: 17 — Over the past two decades, accumulating evidence has implicated the role of glutamatergic dysfunction in the pathophysiology of schizophrenia. Positron emission tomography scanning has shown a correlation between  Автор: G Tsai · 2002 · Цитируется: 809 — Schizophrenia is a chronic, severely disabling brain disorder with symptomatic onset in early adulthood. Автор: JM Stone · 2011 · Цитируется: 102 — Growing evidence for glutamate abnormalities in schizophrenia support the development of novel antipsychotic agents targeting this system. Ketamine is known to mimic symptoms of schizophrenia in humans, as well as cause an increase in glutamate levels in the brain. This decrease could be reversed  pathophysiology of schizophrenia, and the glutamatergic system is a target for novel therapeutic interventions in the disorder. We  Автор: AO Kruse · 2022 · Цитируется: 214 — There is little doubt that brain glutamatergic abnormalities are present in schizophrenia and that some of these are related to the etiology of the illness. The pathogenesis of schizophrenia may be caused by dysfunction of NMDARs or of the glutamatergic system in general. , hypofrontality) in schizophrenia remain unclear. Neuropsychopharmacology. Автор: G Tsai · 2002 · Цитируется: 809 — Schizophrenia is a chronic, severely disabling brain disorder with symptomatic onset in early adulthood. Both studies reported no differences in Glx levels  Автор: I Varvari · 2025 · Цитируется: 9 — Aberrant dopamine and glutamate signaling are implicated in the pathophysiology of schizophrenia. However, the mechanisms underlying these changes remain  Автор: F Iasevoli · 2014 · Цитируется: 67 — Glutamatergic dysfunction has long been suggested to involve an imbalance in the amount and distribution pattern of glutamate receptors in key cerebral areas. Автор: A Egerton · 2017 · Цитируется: 113 — Our recent meta-analysis suggests that schizophrenia is associated with a general elevation in glutamate metabolites, with some variation observed across brain  Автор: AM Dias · 2012 · Цитируется: 9 — This paper aims to introduce a new etiological model that integrates the glutamatergic and the WM (WM) hypotheses of schizophrenia's etiology. first-episode psychosis, schizophrenia, treatment  Автор: JW Olney · 1995 · Цитируется: 2269 — In this article, we advance a unified hypothesis pertaining to combined dysfunction of dopamine and N-methyl-D-aspartate glutamate receptors that highlights  Автор: C Tamminga · 1999 · Цитируется: 161 — Imaging studies provide indirect evidence that glutamate may be involved in schizophrenia. The glutamate hypothesis of  Dysfunction of glutamatergic neurotransmission may play an important role in the pathophysiology of schizophrenia, especially of the negative symptoms and  Автор: A Egerton · 2017 · Цитируется: 113 — Schizophrenia is associated with brain glutamate dysfunction, but it is currently unclear whether antipsychotic administration can reduce the extent of  Автор: M Laruelle · 2014 · Цитируется: 279 — D2 receptor dysfunction can reduce glutamate NMDA transmission. To better Cortical glutamatergic markers in schizophrenia. 29, p =  Recent discoveries extend our understanding of the neurochemistry of schizophrenia, with increasing evidence of dysfunction in glutamate and  An increased copy number of glycine decarboxylase (GLDC) associated with psychosis reduces extracellular glycine and impairs NMDA receptor function. 66, 95% CI -1. Автор: P Shah · 2020 · Цитируется: 58 — Treatment-resistant schizophrenia may be related to structural brain alterations. This paper  Автор: JT Coyle · 2016 · Цитируется: 8 — Positron emission tomographyhas been the dominant method for probing the neurochemistry of psychiatric disorders in living humans. Автор: J Kumar · 2020 · Цитируется: 203 — One meta-analysis found that glutamate is reduced and glutamine is increased in the ACC in patients with schizophrenia, and both decrease more  The glutamatergic system is now a major focus for the development of new compounds in schizophrenia. At the EM level, schizophrenia  Автор: S Thiebes · 2017 · Цитируется: 50 — Smaller MMN amplitudes were specifically associated with more pronounced negative symptoms. Source analysis of MMN generators indicated a significantly reduced  Автор: G Tsai · 1998 · Цитируется: 99 — These findings suggested that some aspects of schizophrenia are associated with decreased NMDA--glutamatergic function. Accumulating evidence suggests that glutamatergic dysfunction may contribute to the pathogenesis of schizophrenia, and the symptoms and cognitive deficits. Автор: JT Coyle · 2006 · Цитируется: 1267 — The accretion of evidence in support of the hypothesis that hypofunction of NMDA receptors contributes to the symptoms of schizophrenia, especially the  Автор: TL Schwartz · 2012 · Цитируется: 305 — This paper will now focus, not only on the NMDA Receptor Hypofunctioning Hypothesis of schizophrenia, but more globally investigate how a faulty glutamatergic  Автор: M Beneyto · 2006 · Цитируется: 2 — These convergent findings implicate altered glutamate neurotransmission in the pathophysiology of schizophrenia, and suggest that novel therapeutic strategies  Автор: TL Schwartz · 2012 · Цитируется: 305 — This now generates psychotic positive symptoms of schizophrenia. Binding of PCP prevents glutamate from activating NMDARs, which suggests that the pathogenesis of schizophrenia may be caused by dysfunction of  Автор: EHX Thomas · 2017 · Цитируется: 57 — The glutamatergic system appears to contribute to the cognitive deficits in schizophrenia, whereby different parts of the pathway are associated with different  Автор: SR Hirsch · 1997 · Цитируется: 158 — There is mounting evidence of a glutamate dysfunction in schizophrenia, as suggested by the fact that schizophrenia and phencyclidine psychosis are similar  Glutamate signaling in the pathophysiology and therapy of schizophrenia ; CLChieh-Hsin Lin ; HLHsien-Yuan Lane ; GTGuochuan E. To better understand the changes in cortical glutamatergic markers in schizophrenia  The drug PCP acts on glutamate receptors, producing schizophrenia-like symptoms. Typical antipsychotic medications  Автор: O Howes · 2015 · Цитируется: 1131 — The disorder is characterised by psychotic symptoms such as delusions and hallucinations, negative symptoms such as social withdrawal and amotivation, and  Автор: A Sawa · 2009 · Цитируется: 15 — Brains of patients with schizophrenia (SZ) show both anatomical and functional deficits that suggest aberrant glutamate neurotransmission. Effects of NMDAR  Автор: J Kantrowitz · 2012 · Цитируется: 203 — Purpose of review: The past 20 years have seen the glutamatergic hypothesis go from theory to phase III trials of novel mechanism antipsychotics. Автор: JJ Lopes · 2024 · Цитируется: 13 — The glutamate hypothesis for schizophrenia asserts that glutamatergic dysfunction is a key causal contributor to both the pathogenesis and the  Автор: RA Bressan · 2003 · Цитируется: 39 — Although dopamine dysfunction in schizophrenia is unequivocal, there are many evidences suggesting the involvement of the glutamatergic system. Typical antipsychotic medications that block  Автор: JR Bustillo · 2011 · Цитируется: 132 — Cognitive deficits in schizophrenia may be related to glutamatergic dysfunction, but in vivo measurement of glutamate metabolism has been challenging. Schizophrenia is increasingly understood as a disorder of glutamatergic signalling, in which hypofunction of the N-methyl-D-aspartate (NMDA)  Автор: M Haaf · 2018 · Цитируется: 57 — The glutamate hypothesis of schizophrenia is based on findings of increased symptom severity in patients with schizophrenia and the emergence of schizophrenia-  Автор: C Tamminga · 1999 · Цитируется: 160 — Diminished glutamatergic neurotransmission in the hippocampal gluatamate-mediated efferent pathways and cerebral dysfunction in the hippocampus and its target  Автор: A Marsman · 2013 · Цитируется: 641 — Group-by-age associations revealed that in patients with schizophrenia, glutamate and glutamine concentrations decreased at a faster rate with age as compared  Автор: S Bleich · 2001 · Цитируется: 24 — It has been suggested that reduced glutamate neurotransmission may be involved in the pathophysiology of schizophrenia. Glutamate and the Glutamate Hypothesis Hi, thanks for watching this video about causes of schizophrenia. Автор: SA Buck · 2022 · Цитируется: 110 — Despite increasing awareness of the complex polygenic and environmental interrelationships that contribute to schizophrenia pathogenesis, dysfunction in brain  Автор: TL Perry · 1982 · Цитируется: 168 — This hypothesis suggests that there may be a dysfunction of glutamatergic neurons in schizophrenia, with either a degeneration of these neurons, or their  Автор: JT Coyle · 2012 · Цитируется: 246 — As a consequence, disinhibition of glutamatergic efferents disrupts cortical processing, causing cognitive impairments and negative symptoms, and drives  Another suggested mechanism involves a dysfunction in glutamate-dopaminergic interactions which supports the glutamatergic hypothesis of schizophrenia [7] [8][9  This Commentary briefly explains how dopamine dysfunction affects the symptoms of schizophrenia, why dopamine as a treatment target may limit  Автор: M Haaf · 2018 · Цитируется: 57 — glutamatergic dysfunction in pharmacological models of schizophrenia glutamatergic dysfunction in pharmacological models of schizophrenia. Thus, a new hypothesis was formed, called the glutamate hypothesis, which postulates that schizophrenia results from the hypofunction of the glutamatergic  Автор: CA Tamminga · 1998 · Цитируется: 529 — We propose a "working" glutamate hypothesis of schizophrenia which postulates a diminished glutamatergic dysfunction in the hippocampus and its target areas,  We consider the case for glutamatergic excitotoxicity as a key process in the development and progression of schizophrenia, and suggest ways in which glutamate  Автор: J Kantrowitz · 2012 · Цитируется: 203 — The glutamatergic hypothesis has since been expanded to include a potential role for dysfunction at other subtypes of glutamatergic receptors, as well as . Altered balance of excitatory and inhibitory learning in a genetically modified mouse model of glutamatergic dysfunction relevant to schizophrenia. – i. Tsai. dfxh, 4tjaq, uvxyw, 1k, coklodl, 42zx8, imdjo, vwk, f8m, v9g,